Erbersdobler A - Search Results

1

Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer.

Mosquera JM, Beltran H, Park K, MacDonald TY, Robinson BD, Tagawa ST, Perner S, Bismar TA, Erbersdobler A, Dhir R, Nelson JB, Nanus DM, Rubin MA. Mosquera JM, et al. Among authors: erbersdobler a. Neoplasia. 2013 Jan;15(1):1-10. doi: 10.1593/neo.121550. Neoplasia. 2013. PMID: 23358695 Free PMC article.

2

Prostate cancer with Paneth cell-like neuroendocrine differentiation has recognizable histomorphology and harbors AURKA gene amplification.

Park K, Chen Z, MacDonald TY, Siddiqui J, Ye H, Erbersdobler A, Shevchuk MM, Robinson BD, Sanda MG, Chinnaiyan AM, Beltran H, Rubin MA, Mosquera JM. Park K, et al. Among authors: erbersdobler a. Hum Pathol. 2014 Oct;45(10):2136-43. doi: 10.1016/j.humpath.2014.06.008. Epub 2014 Jun 26. Hum Pathol. 2014. PMID: 25128228 Free PMC article.

3

Contemporary grading for prostate cancer: implications for patient care.

Brimo F, Montironi R, Egevad L, Erbersdobler A, Lin DW, Nelson JB, Rubin MA, van der Kwast T, Amin M, Epstein JI. Brimo F, et al. Among authors: erbersdobler a. Eur Urol. 2013 May;63(5):892-901. doi: 10.1016/j.eururo.2012.10.015. Epub 2012 Oct 17. Eur Urol. 2013. PMID: 23092544 Review.

4

Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors.

Kattan MW, Eastham JA, Wheeler TM, Maru N, Scardino PT, Erbersdobler A, Graefen M, Huland H, Koh H, Shariat S, Slawin KM, Ohori M. Kattan MW, et al. Among authors: erbersdobler a. J Urol. 2003 Nov;170(5):1792-7. doi: 10.1097/01.ju.0000091806.70171.41. J Urol. 2003. PMID: 14532778

5

International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy.

Graefen M, Karakiewicz PI, Cagiannos I, Quinn DI, Henshall SM, Grygiel JJ, Sutherland RL, Stricker PD, Klein E, Kupelian P, Skinner DG, Lieskovsky G, Bochner B, Huland H, Hammerer PG, Haese A, Erbersdobler A, Eastham JA, de Kernion J, Cangiano T, Schröder FH, Wildhagen MF, van der Kwast TH, Scardino PT, Kattan MW. Graefen M, et al. Among authors: erbersdobler a. J Clin Oncol. 2002 Aug 1;20(15):3206-12. doi: 10.1200/JCO.2002.12.019. J Clin Oncol. 2002. PMID: 12149292

6

Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer.

Minner S, Jessen B, Stiedenroth L, Burandt E, Köllermann J, Mirlacher M, Erbersdobler A, Eichelberg C, Fisch M, Brümmendorf TH, Bokemeyer C, Simon R, Steuber T, Graefen M, Huland H, Sauter G, Schlomm T. Minner S, et al. Among authors: erbersdobler a. Clin Cancer Res. 2010 Mar 1;16(5):1553-60. doi: 10.1158/1078-0432.CCR-09-2546. Epub 2010 Feb 23. Clin Cancer Res. 2010. PMID: 20179235

7

Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement?

Cagiannos I, Graefen M, Karakiewicz PI, Ohori M, Eastham JA, Rabbani F, Fair W, Wheeler TM, Hammerer PG, Haese A, Erbersdobler A, Huland H, Scardino PT, Kattan MW. Cagiannos I, et al. Among authors: erbersdobler a. J Clin Oncol. 2002 Apr 15;20(8):2025-30. doi: 10.1200/JCO.2002.08.123. J Clin Oncol. 2002. PMID: 11956261

8

Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.

Schlomm T, Kirstein P, Iwers L, Daniel B, Steuber T, Walz J, Chun FH, Haese A, Kollermann J, Graefen M, Huland H, Sauter G, Simon R, Erbersdobler A. Schlomm T, et al. Among authors: erbersdobler a. Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6579-84. doi: 10.1158/1078-0432.CCR-07-1257. Clin Cancer Res. 2007. PMID: 18006757

9

From gene to clinic: TMA-based clinical validation of molecular markers in prostate cancer.

Schlomm T, Chun FKh, Erbersdobler A. Schlomm T, et al. Among authors: erbersdobler a. Methods Mol Biol. 2010;664:177-89. doi: 10.1007/978-1-60761-806-5_17. Methods Mol Biol. 2010. PMID: 20690063

10

Prognostic relevance of Bcl-2 overexpression in surgically treated prostate cancer is not caused by increased copy number or translocation of the gene.

Fleischmann A, Huland H, Mirlacher M, Wilczak W, Simon R, Erbersdobler A, Sauter G, Schlomm T. Fleischmann A, et al. Among authors: erbersdobler a. Prostate. 2012 Jun 15;72(9):991-7. doi: 10.1002/pros.21504. Epub 2011 Oct 24. Prostate. 2012. PMID: 22024950

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

218 results

Search Page